Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Ionis scores transformational FDA label expansion for Tryngolza
After 35 years engaged in the research and development of pharmaceutical products, Ionis began marketing its drugs for the first time in 2024. | Ionis has gained an FDA expansion for Tryngolza to become the first treatment specifically approved for severe hypertriglyceridemia. The nod will significantly increase the revenue-generating potential of the antisense oligonucleotide drug.
744 words~3 min read
